Jeremy Hon, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Photodynamic Therapy Targeted Therapy Thoracotomy
Dr. Jeremy Hon is a medical oncologist from Huntsville, Alabama who specialized in oncology and had more than 20 years of experience. He got his medical degree at the University of Alabama School of Medicine. He completed a fellowship in oncology and his residency in internal medicine at the University of Texas Health Science Center. He is associated with Huntsville Hospital and Crestwood Medical Center.
University of Alabama
Medical School
University of Texas Health Science Center
Residency
University of Texas Health Science Center
Fellowship
American Board of Internal Medicine - Oncology
Patient-Reported Neuropathy and Taxane-Associated Symptoms in a Phase 3 Trial of nab-Paclitaxel Plus Carboplatin versus Solvent-Based Paclitaxel Plus Carboplatin for A...
Hirsh, V.,Okamoto, I.,Hon, J. K.,Page, R. D.,Orsini, J.,Sakai, H.,Zhang, H.,Renschler, M. F.,Socinski, M. A.; J Thorac Oncol. 2013 Dec 19.
See more >>Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.
Dillman, R.O., Schreeder, M.T., Hon, J.K., Connelly, E.F., DePriest, C., Cutter, K.; Cancer Biother Radiopharm. 2007 Apr.
See more >>Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minni...
Hainsworth, J.D., Gray, J.R., Morrissey, L.H., Kalman, L.A., Hon, J.K., Greco, F.A.; J Clin Oncol. 2002 Jul 1.
See more >>American Society of Clinical Oncology